PSNC Briefing 014/22: HRT Serious Shortage Protocols (SSPs) FAQs
PSNC Briefing 014/22: HRT Serious Shortage Protocols (SSPs) FAQs
In response to a significant ongoing disruption affecting three Hormone Replacement Therapy (HRT) medicines, the Department of Health and Social Care (DHSC) have issued three new Serious Shortage Protocols (SSPs).
PSNC’s briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ provides answers to commonly asked FAQs around the new SSPs issued on 29 April 2022 for the three HRT medicines:
| HRT medicine | SSP number | Expiry date* |
| Oestrogel® Pump-Pack 0.06% gel | SSP019 | 29 July 2022 |
| Ovestin® 1mg cream | SSP020 | 29 July 2022 |
| Premique® Low Dose 0.3mg/1.5mg modified-release tablets | SSP021 | 29 July 2022 |
If you have queries on this PSNC Briefing or require more information, please contact info@psnc.org.uk.
